Inhaled Nitric Oxide Delivery Systems Market To Grow Substantially At A CAGR Of 6.9% By 2028

Comments · 318 Views

The global inhaled nitric oxide delivery systems market size was valued at USD 247.5 million in 2020 and is projected to grow at a compound annual growth rate (CAGR) of 6.9% from 2021 to 2028.

Inhaled Nitric Oxide Delivery Systems Industry Overview

The global inhaled nitric oxide delivery systems market size was valued at USD 247.5 million in 2020 and is projected to grow at a compound annual growth rate (CAGR) of 6.9% from 2021 to 2028. 

Inhaled Nitric Oxide (INO), a minimally invasive therapy, is proposed to treat conditions associated with reversible pulmonary vasoconstriction and pulmonary hypertension in children and adults. Improved safety and efficacy, a rapid offset of action, reduced toxicity, high concentration of drug at the target organ, avoidance of systemic adverse reaction, and reduced dose of medication are some of the advantages of INO over other medication. This is leading to the improved adoption of INO, potentially driving the market growth.

Gather more insights about the market drivers, restrains and growth of the Global Inhaled Nitric Oxide Delivery Systems Market

In vitro studies suggest that INO is effective in suppressing the SARS-CoV-2 virus treating the diseases as efficiently as the current medication. In addition, INO is effective in treating Acute Respiratory Distress Syndrome (ARDS), the main characteristic of COVID-19–positive patients. Furthermore, studies suggest that INO increases the oxygenation within the bloodstream of COVID-positive patients but has no effect on mortality.

Leading market players like Mallinckrodt Pharmaceuticals are demonstrating the inhibitory effect of INO against the SARS-CoV-2 virus. It is proved to be effective in improving blood oxygen levels, reduction in supplemental oxygen, and a reduction in the amount of ventilator support. Further studies by researchers would confirm the benefits of nitric oxide in the treatment of coronavirus. Interestingly, the year 2020, witnessed an alarming need for nitric oxide devices and disposables, however, global lockdowns, closure of supply chains, and lack of raw material availability led to the drop in sales, negatively impacting the market.

Browse through Grand View Research's Medical Devices Industry Research Reports

  • Air Ambulance Services Market: The global air ambulance services market size was valued at USD 15.73 billion in 2021 and is projected to expand at a compound annual growth rate (CAGR) of 10.6% from 2022 to 2030.
  • Posture Correction MarketThe global posture correction market size was estimated at USD 1.02 billion in 2021 and is anticipated to grow at a compound annual growth rate (CAGR) of 7.9% from 2022 to 2030.

Inhaled Nitric Oxide Delivery Systems Market Segmentation

 

Grand View Research has segmented the global inhaled nitric oxide delivery systems market on the basis of type, product, application, end user, and region:

INO Delivery Systems Type Outlook (Revenue, USD Million, 2016 - 2028)

  • Pediatrics
  • Adult

INO Delivery Systems Application Outlook (Revenue, USD Million, 2016 - 2028)

  • Hypoxic Respiratory Failure (HRF)
  • Acute Hypoxemic Respiratory Failure (AHRF)
  • Others

INO Delivery Systems Product Outlook (Revenue, USD Million, 2016 - 2028)

  • Disposables
  • System

INO Delivery Systems End-user Outlook (Revenue, USD Million, 2016 - 2028)

  • Hospitals
  • Ambulatory Centers
  • Clinics

INO Delivery Systems Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East Africa 

Key Companies profiled:

Some of the prominent players operating in the global inhaled nitric oxide delivery systems market include:

  • Mallinckrodt Pharmaceuticals
  • Getinge
  • Vero Biotech
  • LINDE
  • Beyond Air
  • SLE
  • NU MED
  • Bellerophon Therapeutics
  • Air Liquide Healthcare
  • Circassia Pharmaceuticals 

Order a free sample PDF of the Inhaled Nitric Oxide Delivery Systems Market Intelligence Study, published by Grand View Research. 

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Follow Us: LinkedIn | Twitter

 

Comments